Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies

Edo Kapetanovic(ETH Zurich), Sai T. Reddy(ETH Zurich)
Nature Biomedical Engineering
September 25, 2024
Cited by 3


Related Papers